Double Medical(SZ:002901) Sou Hu Cai Jing·2025-12-18 14:15Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Dabo Medical (002901) as of December 18, 2025, with a closing price of 48.87 yuan, reflecting a 0.74% increase [1] - Dabo Medical's main business involves the production, research, and sales of high-value medical consumables [2] - The company reported a total revenue of 1.876 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 22.69%, and a net profit attributable to shareholders of 425 million yuan, up 77.03% year-on-year [2] Group 2 - In Q3 2025, Dabo Medical achieved a quarterly revenue of 666 million yuan, which is a 17.82% increase compared to the same quarter last year, and a net profit of 180 million yuan, reflecting a 77.49% year-on-year growth [2] - The company's financial metrics include a debt ratio of 24.53%, investment income of 5.81 million yuan, financial expenses of -23.87 million yuan, and a gross profit margin of 71.23% [2] - Over the last 90 days, one institution has given a buy rating for Dabo Medical [3]